Klinische Studie NACRE

AP-HP Sorbonne Université·Paris Cedex 13, France·Expired · Jul 20, 2026·Open·Supplies·Framework

Registrieren zum Speichern Open documents

Originaltitel der Bekanntmachung

France – Pharmaceutical products – DEC : Essai clinique NACRE

55/100

Opportunity Score

Needs reviewHigh complexity

SuppliesFrameworkExpired

Warum diese Bewertung?

Chance

55 / 100

Komplexität

68 / 100

Risikofaktoren

The notice does not provide product details, quantities, delivery requirements, or a contract value, making technical c...

No selection criteria or tenderer qualification requirements are stated in the provided data.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Eckdaten der Ausschreibung

Öffentlicher Auftraggeber: AP-HP Sorbonne Université
Land: Frankreich
CPV: 33600000 - Pharmaceutical products
Frist: Jul 20, 2026

Überblick

Moderate opportunity

Wichtige Fakten

Framework procurement
Supplies contract
1 lot
Duration 48 MONTH
Supply of investigational medicinal products for the double-blind NACRE clinical trial.
The contracting buyer is Assistance Publique Hôpitaux de Paris (AP-HP).

Vollständige Zusammenfassung anzeigen

Open procedure for a 48-month framework agreement concerning the supply of investigational medicinal products for the double-blind NACRE clinical trial promoted by AP-HP. Performance is in France and electronic submission is required through the French public procurement portal. Contract value, eligibility criteria, award criteria, and substantive procurement documents are not available in the provided data. The structured data marks the procurement as EU-funded, while the XML notice states "no EU funds"; this should be clarified.

Risiken

The notice does not provide product details, quantities, delivery requirements, or a contract value, making technical c...

No selection criteria or tenderer qualification requirements are stated in the provided data.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

The procedure is open.

Administrative

Electronic submission is required.
Submission is directed through Portal öffnen

Auftraggeber

Name

AP-HP Sorbonne Université

Ort

Paris Cedex 13, FRA

E-Mail

[email protected]

Website

www.aphp.fr

Auftraggeberprofil

Profil öffnen

Kennung

26750045201928

Tätigkeit

Health

Lose (1)

LOT-0001

NACRE Clinical Trial Investigational Medicines

Supply of investigational medicinal products for the double-blind NACRE clinical trial promoted by AP-HP. The lot is structured as a supply contract and framework agreement with a 48-month duration. Detailed product specifications and quantities are not provided.

SuppliesFrameworkEU fundedElectronic submission

Ort

France

Dauer

48 MONTH

Kategorie

Pharmaceutical products

Frist

Expired Jul 20, 2026

Vergabedetails

Veröffentlichungsdatum: 16 Jun 2026
Sprachen: French

Referenzmetadaten

Rechtsgrundlage: 32014L0024

Referenz-IDs

Ausschreibungs-ID: 415513-2026

Dokumente (1)

Vergabedokument 1